MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2026)

MeiraGTx Holdings' (MGTX) quarterly Other Non Operating Income came in at -$8.6 million in Q4 2025, down 55.64% YoY from -$19.4 million in Q4 2024, and down 452.44% on a QoQ basis from -$1.6 million in Q3 2025.

Analysis

MeiraGTx Holdings (MGTX) Other Non Operating Income (2017 - 2026) Analysis & Trends

MeiraGTx Holdings (MGTX) has 9 years of Other Non Operating Income data on file, last reported at -$8.6 million in Q4 2025.

  • Quarterly Other Non Operating Income fell 55.64% year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (up 174.36% YoY) and the FY2025 annual result came in at $2.1 million, up 174.36% from the prior year.
  • Other Non Operating Income slipped to -$8.6 million in Q4 2025, from -$1.6 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $9.2 million in Q4 2023 to a low of -$12.8 million in Q3 2022.
  • A 5-year average of -$1.5 million and a median of -$1.0 million in 2024 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 2836.48% — and 2025, when it soared 3136.62%.
  • Tracing MGTX's Other Non Operating Income over 5 years: stood at $4.2 million in 2021, then sank by 341.65% to -$10.1 million in 2022, then surged by 191.85% to $9.2 million in 2023, then sank by 159.8% to -$5.5 million in 2024, then sank by 55.64% to -$8.6 million in 2025.
  • The last three Other Non Operating Income figures came in at -$8.6 million (Q4 2025), -$1.6 million (Q3 2025), and $8.6 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.22 Mn
Dec 31, 2025 -8.61 Mn
Sep 30, 2025 -1.56 Mn
Jun 30, 2025 8.62 Mn
Mar 31, 2025 3.69 Mn
Dec 31, 2024 -5.53 Mn
Sep 30, 2024 3.46 Mn
Jun 30, 2024 -284,000.00
Mar 31, 2024 -535,000.00
Dec 31, 2023 12.22 Mn
Sep 30, 2023 -8.68 Mn
Jun 30, 2023 1.91 Mn
Mar 31, 2023 3.86 Mn
Dec 31, 2022 16.46 Mn
Sep 30, 2022 -12.84 Mn
Jun 30, 2022 -10.43 Mn
Mar 31, 2022 -2.65 Mn
Dec 31, 2021 -1.69 Mn
Sep 30, 2021 -3.37 Mn
Jun 30, 2021 381,000.00